677 related articles for article (PubMed ID: 16777975)
1. Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling.
Wang X; Hu Z; Hu J; Du J; Mitch WE
Endocrinology; 2006 Sep; 147(9):4160-8. PubMed ID: 16777975
[TBL] [Abstract][Full Text] [Related]
2. Molecular signaling pathways regulating muscle proteolysis during atrophy.
Franch HA; Price SR
Curr Opin Clin Nutr Metab Care; 2005 May; 8(3):271-5. PubMed ID: 15809529
[TBL] [Abstract][Full Text] [Related]
3. Regulation of muscle protein degradation: coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase.
Lee SW; Dai G; Hu Z; Wang X; Du J; Mitch WE
J Am Soc Nephrol; 2004 Jun; 15(6):1537-45. PubMed ID: 15153564
[TBL] [Abstract][Full Text] [Related]
4. Caulerpa lentillifera extract ameliorates insulin resistance and regulates glucose metabolism in C57BL/KsJ-db/db mice via PI3K/AKT signaling pathway in myocytes.
Sharma BR; Kim HJ; Rhyu DY
J Transl Med; 2015 Feb; 13():62. PubMed ID: 25889508
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle.
Joassard OR; Amirouche A; Gallot YS; Desgeorges MM; Castells J; Durieux AC; Berthon P; Freyssenet DG
Int J Biochem Cell Biol; 2013 Nov; 45(11):2444-55. PubMed ID: 23916784
[TBL] [Abstract][Full Text] [Related]
6. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.
Sacheck JM; Ohtsuka A; McLary SC; Goldberg AL
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E591-601. PubMed ID: 15100091
[TBL] [Abstract][Full Text] [Related]
7. Evidence for adipose-muscle cross talk: opposing regulation of muscle proteolysis by adiponectin and Fatty acids.
Zhou Q; Du J; Hu Z; Walsh K; Wang XH
Endocrinology; 2007 Dec; 148(12):5696-705. PubMed ID: 17761767
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-{alpha} decreases Akt protein levels in 3T3-L1 adipocytes via the caspase-dependent ubiquitination of Akt.
Medina EA; Afsari RR; Ravid T; Castillo SS; Erickson KL; Goldkorn T
Endocrinology; 2005 Jun; 146(6):2726-35. PubMed ID: 15746249
[TBL] [Abstract][Full Text] [Related]
9. Decreased rate of protein synthesis, caspase-3 activity, and ubiquitin-proteasome proteolysis in soleus muscles from growing rats fed a low-protein, high-carbohydrate diet.
Batistela E; Pereira MP; Siqueira JT; Paula-Gomes S; Zanon NM; Oliveira EB; Navegantes LC; Kettelhut IC; Andrade CM; Kawashita NH; Baviera AM
Can J Physiol Pharmacol; 2014 Jun; 92(6):445-54. PubMed ID: 24826789
[TBL] [Abstract][Full Text] [Related]
10. Cellular signals activating muscle proteolysis in chronic kidney disease: a two-stage process.
Du J; Hu Z; Mitch WE
Int J Biochem Cell Biol; 2005 Oct; 37(10):2147-55. PubMed ID: 15982920
[TBL] [Abstract][Full Text] [Related]
11. 1-Deoxynojirimycin Alleviates Insulin Resistance via Activation of Insulin Signaling PI3K/AKT Pathway in Skeletal Muscle of db/db Mice.
Liu Q; Li X; Li C; Zheng Y; Peng G
Molecules; 2015 Dec; 20(12):21700-14. PubMed ID: 26690098
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms involved in 3',5'-cyclic adenosine monophosphate-mediated inhibition of the ubiquitin-proteasome system in skeletal muscle.
Gonçalves DA; Lira EC; Baviera AM; Cao P; Zanon NM; Arany Z; Bedard N; Tanksale P; Wing SS; Lecker SH; Kettelhut IC; Navegantes LC
Endocrinology; 2009 Dec; 150(12):5395-404. PubMed ID: 19837877
[TBL] [Abstract][Full Text] [Related]
13. TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine.
Dogra C; Changotra H; Wedhas N; Qin X; Wergedal JE; Kumar A
FASEB J; 2007 Jun; 21(8):1857-69. PubMed ID: 17314137
[TBL] [Abstract][Full Text] [Related]
14. Decreased Akt kinase activity and insulin resistance in C57BL/KsJ-Leprdb/db mice.
Shao J; Yamashita H; Qiao L; Friedman JE
J Endocrinol; 2000 Oct; 167(1):107-15. PubMed ID: 11018758
[TBL] [Abstract][Full Text] [Related]
15. Activating cAMP/PKA signaling in skeletal muscle suppresses the ubiquitin-proteasome-dependent proteolysis: implications for sympathetic regulation.
Silveira WA; Gonçalves DA; Graça FA; Andrade-Lopes AL; Bergantin LB; Zanon NM; Godinho RO; Kettelhut IC; Navegantes LC
J Appl Physiol (1985); 2014 Jul; 117(1):11-9. PubMed ID: 24833777
[TBL] [Abstract][Full Text] [Related]
16. Transgenic overexpression of locally acting insulin-like growth factor-1 inhibits ubiquitin-mediated muscle atrophy in chronic left-ventricular dysfunction.
Schulze PC; Fang J; Kassik KA; Gannon J; Cupesi M; MacGillivray C; Lee RT; Rosenthal N
Circ Res; 2005 Sep; 97(5):418-26. PubMed ID: 16051886
[TBL] [Abstract][Full Text] [Related]
17. PI3 kinase regulation of skeletal muscle hypertrophy and atrophy.
Glass DJ
Curr Top Microbiol Immunol; 2010; 346():267-78. PubMed ID: 20593312
[TBL] [Abstract][Full Text] [Related]
18. Cardiac muscle protein catabolism in diabetes mellitus: activation of the ubiquitin-proteasome system by insulin deficiency.
Hu J; Klein JD; Du J; Wang XH
Endocrinology; 2008 Nov; 149(11):5384-90. PubMed ID: 18653708
[TBL] [Abstract][Full Text] [Related]
19. Effects of rexinoids on glucose transport and insulin-mediated signaling in skeletal muscles of diabetic (db/db) mice.
Shen Q; Cline GW; Shulman GI; Leibowitz MD; Davies PJ
J Biol Chem; 2004 May; 279(19):19721-31. PubMed ID: 14998989
[TBL] [Abstract][Full Text] [Related]
20. Absence of caspase-3 protects against denervation-induced skeletal muscle atrophy.
Plant PJ; Bain JR; Correa JE; Woo M; Batt J
J Appl Physiol (1985); 2009 Jul; 107(1):224-34. PubMed ID: 19390003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
